Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier organic anion transporter family member 1B7 (SLCO1B7) is a member of the SLC21A family of solute carriers, formally classified as a putative transporter and pseudogene in humans. It is primarily expressed in the endoplasmic reticulum and plasma membrane of liver cells, and its functional splice variant (LST-3TM12) may contribute to the uptake of organic anions, such as conjugated steroids and bile acids. The gene is notable for its association with pharmacogenomic traits, such as susceptibility to drug-induced neutropenia and myopathy. Unlike other OATP family members (e.g., SLCO1B1, SLCO1B3), it is not considered a functional drug transporter in humans, and thus is generally not a direct therapeutic target for drugs, but may influence drug effects through genetic variation.
Not directly established for drugs, but genetic variants may modify drug metabolism or adverse response via unknown or indirect mechanisms; OATP-type transport (if functional), facilitating cellular uptake of organic anions
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier organic anion transporter family member 1B7 (SLCO1B7).